Patents by Inventor Stephen Pak

Stephen Pak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11931366
    Abstract: The present disclosure relates generally compositions and methods of using the same for the treatment of proteinopathies (e.g. Alpha-1-antitrypsin deficiency, Non-alcoholic fatty liver disease, Alzheimer's disease, Parkinson's disease, Amyotrophic Lateral Sclerosis, and Huntington's disease) with one or more proteotoxicity reducing agents.
    Type: Grant
    Filed: April 19, 2019
    Date of Patent: March 19, 2024
    Assignee: Washington University
    Inventors: Stephen Pak, David Perlmutter, Gary Silverman
  • Publication number: 20210228591
    Abstract: The present disclosure relates generally compositions and methods of using the same for the treatment of proteinopathies (e.g. Alpha-1-antitrypsin deficiency, Non-alcoholic fatty liver disease, Alzheimer's disease, Parkinson's disease, Amyotrophic Lateral Sclerosis, and Huntington's disease) with one or more proteotoxicity reducing agents.
    Type: Application
    Filed: April 19, 2019
    Publication date: July 29, 2021
    Inventors: Stephen Pak, David Perlmutter, Gary Silverman